Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015 Jan 1;372(1):11-20.
doi: 10.1056/NEJMoa1411587. Epub 2014 Dec 17.

A randomized trial of intraarterial treatment for acute ischemic stroke

Collaborators, Affiliations
Free article
Clinical Trial

A randomized trial of intraarterial treatment for acute ischemic stroke

Olvert A Berkhemer et al. N Engl J Med. .
Free article

Erratum in

  • N Engl J Med. 2015 Jan 22;372(4):394

Abstract

Background: In patients with acute ischemic stroke caused by a proximal intracranial arterial occlusion, intraarterial treatment is highly effective for emergency revascularization. However, proof of a beneficial effect on functional outcome is lacking.

Methods: We randomly assigned eligible patients to either intraarterial treatment plus usual care or usual care alone. Eligible patients had a proximal arterial occlusion in the anterior cerebral circulation that was confirmed on vessel imaging and that could be treated intraarterially within 6 hours after symptom onset. The primary outcome was the modified Rankin scale score at 90 days; this categorical scale measures functional outcome, with scores ranging from 0 (no symptoms) to 6 (death). The treatment effect was estimated with ordinal logistic regression as a common odds ratio, adjusted for prespecified prognostic factors. The adjusted common odds ratio measured the likelihood that intraarterial treatment would lead to lower modified Rankin scores, as compared with usual care alone (shift analysis).

Results: We enrolled 500 patients at 16 medical centers in The Netherlands (233 assigned to intraarterial treatment and 267 to usual care alone). The mean age was 65 years (range, 23 to 96), and 445 patients (89.0%) were treated with intravenous alteplase before randomization. Retrievable stents were used in 190 of the 233 patients (81.5%) assigned to intraarterial treatment. The adjusted common odds ratio was 1.67 (95% confidence interval [CI], 1.21 to 2.30). There was an absolute difference of 13.5 percentage points (95% CI, 5.9 to 21.2) in the rate of functional independence (modified Rankin score, 0 to 2) in favor of the intervention (32.6% vs. 19.1%). There were no significant differences in mortality or the occurrence of symptomatic intracerebral hemorrhage.

Conclusions: In patients with acute ischemic stroke caused by a proximal intracranial occlusion of the anterior circulation, intraarterial treatment administered within 6 hours after stroke onset was effective and safe. (Funded by the Dutch Heart Foundation and others; MR CLEAN Netherlands Trial Registry number, NTR1804, and Current Controlled Trials number, ISRCTN10888758.).

PubMed Disclaimer

Comment in

Similar articles

  • Randomized assessment of rapid endovascular treatment of ischemic stroke.
    Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jovin TG, Willinsky RA, Sapkota BL, Dowlatshahi D, Frei DF, Kamal NR, Montanera WJ, Poppe AY, Ryckborst KJ, Silver FL, Shuaib A, Tampieri D, Williams D, Bang OY, Baxter BW, Burns PA, Choe H, Heo JH, Holmstedt CA, Jankowitz B, Kelly M, Linares G, Mandzia JL, Shankar J, Sohn SI, Swartz RH, Barber PA, Coutts SB, Smith EE, Morrish WF, Weill A, Subramaniam S, Mitha AP, Wong JH, Lowerison MW, Sajobi TT, Hill MD; ESCAPE Trial Investigators. Goyal M, et al. N Engl J Med. 2015 Mar 12;372(11):1019-30. doi: 10.1056/NEJMoa1414905. Epub 2015 Feb 11. N Engl J Med. 2015. PMID: 25671798 Clinical Trial.
  • Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN).
    Yoo AJ, Berkhemer OA, Fransen PSS, van den Berg LA, Beumer D, Lingsma HF, Schonewille WJ, Sprengers MES, van den Berg R, van Walderveen MAA, Beenen LFM, Wermer MJH, Nijeholt GJLÀ, Boiten J, Jenniskens SFM, Bot JCJ, Boers AMM, Marquering HA, Roos YBWEM, van Oostenbrugge RJ, Dippel DWJ, van der Lugt A, van Zwam WH, Majoie CBLM; MR CLEAN investigators. Yoo AJ, et al. Lancet Neurol. 2016 Jun;15(7):685-694. doi: 10.1016/S1474-4422(16)00124-1. Epub 2016 May 9. Lancet Neurol. 2016. PMID: 27302238 Clinical Trial.
  • Thrombectomy within 8 hours after symptom onset in ischemic stroke.
    Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, San Román L, Serena J, Abilleira S, Ribó M, Millán M, Urra X, Cardona P, López-Cancio E, Tomasello A, Castaño C, Blasco J, Aja L, Dorado L, Quesada H, Rubiera M, Hernandez-Pérez M, Goyal M, Demchuk AM, von Kummer R, Gallofré M, Dávalos A; REVASCAT Trial Investigators. Jovin TG, et al. N Engl J Med. 2015 Jun 11;372(24):2296-306. doi: 10.1056/NEJMoa1503780. Epub 2015 Apr 17. N Engl J Med. 2015. PMID: 25882510 Clinical Trial.
  • Endovascular vs medical management of acute ischemic stroke.
    Chen CJ, Ding D, Starke RM, Mehndiratta P, Crowley RW, Liu KC, Southerland AM, Worrall BB. Chen CJ, et al. Neurology. 2015 Dec 1;85(22):1980-90. doi: 10.1212/WNL.0000000000002176. Epub 2015 Nov 4. Neurology. 2015. PMID: 26537058 Free PMC article. Review.
  • Stent Retrievers for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Touma L, Filion KB, Sterling LH, Atallah R, Windle SB, Eisenberg MJ. Touma L, et al. JAMA Neurol. 2016 Mar;73(3):275-81. doi: 10.1001/jamaneurol.2015.4441. JAMA Neurol. 2016. PMID: 26810499 Review.

Cited by

Publication types

MeSH terms

Substances